Osiris Therapeutics

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Osiris Therapeutics
Public
Traded as NASDAQOSIR
Industry Pharmaceuticals
Headquarters Columbia, Maryland, United States
Key people
Dwayne Montgomery(CEO), Greg Law (CFO), Frank Czworka (COO), Alla Danilkovitch (CSO), Jon Hopper (CMO)
Products Grafix, Cartiform, BIO4,
Website osiris.com

Osiris Therapeutics, Inc., based in Columbia, Maryland, is a company researching, developing and marketing regenerative medicine products. One of its products, Stromagen was used to treat breast cancer in clinical trials.[1]

References[edit]

  1. ^ "Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. May 11, 2017. Retrieved May 11, 2017.  This article incorporates text from this source, which is in the public domain.